Lataa...
STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
BACKGROUND: Mutations in STK11 (STK11m) and frequently co-occurring KRAS mutations (KRASm/STK11m) are associated with poor survival in metastatic NSCLC (mNSCLC) immuno-oncology trials. There are limited data regarding the prognostic significance of these mutations in a real-world setting. METHODS: T...
Tallennettuna:
| Julkaisussa: | PLoS One |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470384/ https://ncbi.nlm.nih.gov/pubmed/32881920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0238358 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|